JESSICA CLIATT: Open Payments
NPI 1114526753 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 23 payments from 8 companies in 2025. Trend: 2023 $666 · 2024 $486 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $272 |
| Merck Sharp & Dohme LLC | 4 | $107 |
| AstraZeneca Pharmaceuticals LP | 3 | $90 |
| Caris MPI, Inc. | 3 | $85 |
| Eisai Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| ABBVIE INC. | 1 | $20 |
| Coherus Oncology, Inc. | 1 | $19 |
Products named: TIVDAK, LYNPARZA, MI CANCER SEEK, Lenvima, KEYTRUDA, JEMPERLI, ELAHERE, Udenyca.
Industry payments across GA — which companies pay providers there.
